This suggests renal protective effects that extend beyond blood sugar control
Both albiglutide and dulaglutide received FDA approval for the treatment of T2DM in 2014, with dulaglutide having an additional indication since 2020 to reduce the risk of major adverse cardiovascular events (MACE) in adults with T2DM and established cardiovascular disease or multiple cardiovascular risk factors [ Table 2 ]
ZipHealth analyzed thousands of posts across four GLP-1 communities on Reddit to see which foods are talked about most, which spark the strongest feelings, and which people say they can't stomach anymore
While the prevalence of these conditions is expected to be lower in fully underwritten insured populations compared to the general population, no population including countries in Asia with lower prevalence is immune to these global trends
Glucagon-like peptide-1, a new hormone of the entero-insular axis
When is baseline adjustment useful in analyses of change